P. Comella, “Baseline physical functioning status of metastatic colorectal cancer patients predicts the overall survival but not the activity of a front-line oxaliplatin-fluoropyrimidine doublet”, AO, vol. 49, no. 1, pp. 50–56, Jan. 2010.